Breber Pierre R, Vice President and Chief Financial Officer, has been an active filer across four companies, with 67 total Form 4 transactions. The aggregate dollar picture shows a net seller: open-market sales totaled $1.54 million against open-market purchases of $1.04 million, with an additional $809,032 in acquired shares (mostly grants and option exercises). The recent pattern, however, is more nuanced. The only open-market purchase (code P) in the last six months was a $429,124 buy of Clorox (CLX) on May 5, 2026. That same period shows no open-market sales (code S), suggesting a pause in the selling that defined the broader history.
The bulk of recent activity is in Paccar (PCAR), where Breber holds the CFO title. A series of "J" codes—other acquisitions or dispositions—appear monthly, with values ranging from roughly $1,000 to $50,000. These are likely dividend reinvestments or similar automatic transactions, not discretionary trades. On January 2, 2026, he also received a $175,037 grant (code A) in PCAR. Clorox shows multiple zero-value grants (code A) on dates like June 30 and May 8, 2026, which are compensation awards rather than market transactions. The one notable discretionary move is the CLX purchase, which stands out against the otherwise mechanical flow of grants, exercises, and small PCAR adjustments.
AI-assisted summary